Jeff Macdonald | Head, IR & Public Relations |
Mark Velleca | President & CEO |
Barclay Phillips | CFO & SVP of Corporate Development & Secretary |
Rajesh Malik | Chief Medical Officer & SVP, R&D |
Tessa Romero | JP Morgan Chase |
David Nierengarten | Wedbush Securities |
Chad Messer | Needham & Company |
Edward White | H.C. Wainwright & Company |
Good day, ladies and gentlemen, and welcome to the G1 Therapeutics Third Quarter 2018 Financial Results Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to Jeff Macdonald.
You may begin.
Thank you, operator.